期刊文献+

骨髓间充质干细胞治疗脑梗死的研究进展

Research Progress of Bone Marrow Mesenchymal Stem Cell in the Treatment of Cerebral Infarction
下载PDF
导出
摘要 骨髓间充质干细胞(bone marrow mesenchymal stem cells,BMSCs)是一类具有多项分化潜能的干细胞,通过诱导BMSCs可分化为各胚层细胞。已有动物实验证明,BMSCs治疗能够促进脑梗死后受损神经组织结构和功能的恢复,其可能的机制有:刺激神经发生和突触的形成,分泌多种神经营养因子和细胞因子,发挥免疫调节作用改变缺血区微环境,促进新生血管的形成等。对BMSCs进行修饰处理后,其治疗脑梗死效果更好,临床试验结果较乐观。 Bone marrow mesenchymal stem cells(BMSCs) is a kind of stem cells that have multiple differentiation potential. Through induced, BMSCs can differentiate into each layer cells. Animal experiments proved that BMSCs treatment can promote the recovery of damaged nerve tissue structure and function, and its possible mechanisms are stimulating neurogenesis and the formation of synapses, secreting various neurotrophic factors and cytokines for nerve protection, through the immune adjustment function to change microenvironment of ischemia area, promoting the formation of new blood vessels. Through the modifi cation of BMSCs for treatment, the effect is better, clinical trials have optimistic results.
出处 《中国卒中杂志》 2015年第3期261-266,共6页 Chinese Journal of Stroke
关键词 骨髓间充质干细胞 脑梗死 移植 Bone marrow mesenchymal stem cells Cerebral infarction Transplant
  • 相关文献

参考文献2

二级参考文献27

  • 1陈玲,陈景刚,唐洲平,张广慧,徐光锦,朱遂强.不同培养条件下胚胎神经干细胞分化细胞中神经元所占比例的比较[J].中国康复,2005,20(2):72-75. 被引量:6
  • 2Li W, Prakash R, Kelly-Cobbs AI, et al. Adaptive cerebral neo- vascularization in a model of type 2 diabetes: relevance to focal cerebral ischemia. Diabetes, 2010,59 ( 1 ): 228-235.
  • 3Lin CY, Chang C, Cheung WM, et al. Dynamic changes in vas- cular permeability, cerebral blood volume, vascular density, and size after transient focal cerebral ischemia in rats., evaluation with contrast-enhanced magnetic resonance imaging. J Cereb Blood Flow Metab, 2008, 28(8) : 1491 -1501.
  • 4Krupinski J, Kaluza J, Kumar P, et al. Role of angiogenesis in patients with cerebral isehemic stroke. Stroke, 1994, 25 (9): 1794 -1798.
  • 5Garbern JC, Minami E, Stayton PS, et al. Delivery of basic fi- broblast growth factor with a pH-responsive, injectable hydrogel to improve angiogenesis in infarcted myoeardium. Biomaterials, 2011,32(9) :2407- 2416.
  • 6Marui A, Tabata Y, Kojima S, et al. A novel approach to thera peutic angiogenesis for patients with critical limb ischemia by sus- tained release of basic fibroblast growth factor using biodegrada- ble gelatin hydrogel: an initial report of the phase Ⅰ-Ⅱa study. Circ J, 2007, 71(8):1181 -1186.
  • 7Cui X, Chopp M, Zacharek A, et al. Chemokine, vascular and therapeutic effects of combination Simvastatin and BMSC treat- ment of stroke. Neurobiol Dis, 2009,36 ( 1 ) :35-41.
  • 8Beck H, Raab S, Copanaki E, et al. VEGFR-1 signaling regu- lates the homing of bone marrow-derived cells in a mouse stroke model. J Neuropathol Exp Neurol, 2010, 69(2) : 168- 175.
  • 9Chen J, Zhang ZG, Li Y, et al. Intravenous administration of hu- man bone marrow stromal cells induces angiogenesis in the ische- mic boundary zone after stroke in rats. Circ Res, 2003,92 (6): 692 -699.
  • 10Bao X, Feng M, Wei J, et al. Transplantation of Flk-1 + human bone marrow- derived mesenchymal stem ceils promotes angio- genesis and neurogenesis after cerebral ischemia in rats. Eur J Neurosci, 2011,34 ( 1 ) : 8-7 98.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部